The 2026 Home Health Final Rule: What Agencies Need to Know and Do Now
The CMS Calendar Year (CY) 2026 Home Health Final Rule is official, and while the outcome is better than many agencies feared, it still presents meaningful financial and operational challenges. Effective January 1, 2026, the rule finalizes Medicare payment updates, PDGM recalibrations, quality reporting changes, and refinements to the Home Health Value-Based Purchasing (HHVBP) Model.
Here’s a clear breakdown of what changed, what it means for your agency, and how to prepare.
Big Picture: Smaller Cut, Ongoing Pressure
CMS finalized a net aggregate Medicare payment reduction of approximately 1.3% for home health agencies in 2026. This is significantly less severe than the proposed cut earlier in 2025, which exceeded 6%. Industry advocacy played a major role in softening the final outcome. Still, margins remain tight, and agencies cannot rely on volume alone to offset payment pressure.
Key takeaway: The financial hit is manageable compared to the proposal but only for agencies that actively manage cost, productivity, coding accuracy, and value-based performance.
- 2026 Home Health Payment Rate Updates
The final payment update reflects multiple components:
- Market basket update: +2.4%
- Permanent behavioral adjustment: -1.0%
- Temporary adjustment: -2.7%
When combined, these changes result in a net 1.3% reduction year over year.
Why this matters:
Agencies with high labor costs, poor visit utilization control and low value-based purchasing performance will feel this cute more significantly than agencies with strong operational discipline.
- PDGM Recalibration: Coding and Utilization Matter More Than Ever
CMS continues to recalibrate PDGM case-mix weights using updated utilization data.
What agencies should expect:
- Shifts in reimbursement tied to diagnosis grouping accuracy
- Increased scrutiny of visit patterns by discipline
- Less tolerance for over-utilization without clear clinical justification
What actions should your agency take:
- Audit primary diagnosis selection and sequencing
- Ensure functional and clinical OASIS items support the case-mix group
- Monitor visits per episode by discipline weekly
PDGM success in 2026 depends less on volume and more on precision.
- Quality Reporting Program (HH QRP) Changes
CMS finalized updates to the Home Health Quality Reporting Program, including:
- Removal of certain OASIS items, including some COVID-19 and social determinant elements
- Continued emphasis on standardized patient assessment data
- Ongoing penalties for failure to meet reporting thresholds
What does this mean operationally:
- Agencies should update OASIS training and templates
- QA audits must reflect current year item sets
- Inaccurate or incomplete OASIS data increases both compliance and revenue risk
- Home Health Value-Based Purchasing (HHVBP) Updates
HHVBP continues nationwide and remains one of the largest financial levers agencies can control.
- Performance-based payment adjustments remain up to ±5%
- Measure weighting and scoring methodology are recalibrated
- Functional outcomes and patient experience continue to carry significant weight
Key insight:
Strong HHVBP performance can fully offset or exceed the 1.3% base rate cut.
Agencies that ignore HHVBP strategy are effectively leaving money on the table.
Strategic Implications for Home Health Leaders
- Financial Management Must Be Proactive
Agencies should monitor:
- Cost per visit
- Visits per episode
- Discipline productivity
- Margin by payer and diagnosis group
Waiting until month-end financials is too late in today’s environment.
- Clinical Documentation Is a Revenue Function
In 2026, documentation accuracy directly affects:
- PDGM reimbursement
- Quality scores
- HHVBP payments
Clinical and financial teams must operate in alignment.
- Volume Alone Will Not Sustain You
Growth without margin control increases risk. Agencies should prioritize:
- Referral sources with appropriate acuity
- Patients who align with staffing capacity
- Disciplines that contribute positively to episode margin
What Agencies Should Do Before January 1, 2026:
- Update budgets using the finalized rates
- Re-forecast revenue by case-mix group
- Retrain clinicians on updated OASIS and documentation expectations
- Review HHVBP performance trends and target low-scoring measures
In Q1 2026:
- Track actual vs projected PDGM reimbursement
- Monitor visit utilization weekly
- Audit top diagnoses monthly
- Adjust staffing models as needed
Final Thoughts
The 2026 Home Health Final Rule is not catastrophic, but it is another reminder that operational excellence is no longer optional. Agencies that understand their data, manage utilization, and perform well in value-based purchasing will remain financially stable. Those that don’t will continue to feel squeezed.
The agencies that win in 2026 will be the ones that treat compliance, quality, and finance as a single strategy not separate silo. Contact Proactive Home Health consulting if you are facing challenges related to success with the 2026 final rule.
Written By:
Nichole McClain, RN
Principal Consultant of Home Health Services
Proactive Medical Review
Contact Proactive to learn more about Five-Star Improvement support services and develop a road map to Five-Star success in 2025.